https://www.selleckchem.com/EGFR(HER).html
Sodium nitroprusside (SNP) is a potent vasodilator that first gained FDA approval for the treatment of severe hypertension in 1974. First discovered in 1849 by Playfair, its applications in human medicine can be traced back to the early 1920s, with the first safety and efficacy data published in 1955. After an initial delay in gaining FDA approval due to difficulty in development of a chemically stable formulation, SNP gained widespread use as a fast-acting antihypertensive agent and has been used clinically for hypertensive crises, heart fail
Gefällt mir
Kommentar
Teilen
